S Fujimura Selected Research

S Fujimura Research Topics

Disease

14	Neoplasms (Cancer) 08/2004 - 01/2000
6	Lung Neoplasms (Lung Cancer) 07/2001 - 01/2000
4	Infections 03/2014 - 12/2001
2	Inflammation (Inflammations) 09/2011 - 08/2004
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2001 - 06/2000
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 03/2001 - 01/2001
2	Brain Death (Brain Dead) 11/2000 - 11/2000
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2000 - 01/2000
1	Lymphangioleiomyomatosis (Lymphangiomyomatosis) 07/2009
1	Frostbite 11/2006
1	Cardiac Tamponade 08/2004
1	Pericardial Effusion 08/2004
1	Gingival Overgrowth 06/2004
1	Hyperplasia 06/2004
1	Hypertension (High Blood Pressure) 06/2004
1	Pneumonia (Pneumonitis) 12/2001
1	Pulmonary Hypertension 04/2001
1	Right Ventricular Hypertrophy 04/2001
1	Hypoxia (Hypoxemia) 04/2001
1	Carcinoma (Carcinomatosis) 01/2001
1	Hyperparathyroidism 01/2001
1	Secondary Hyperparathyroidism 01/2001
1	Pulmonary Edema 01/2001
1	Eisenmenger Complex (Eisenmenger's Syndrome) 11/2000
1	Idiopathic Pulmonary Fibrosis 11/2000
1	Pneumoconiosis 11/2000
1	Bronchiectasis 11/2000
1	Familial Primary Pulmonary Hypertension 11/2000
1	Hemorrhage 11/2000
1	Chylothorax 11/2000
1	Bronchiolitis Obliterans 11/2000
1	Tympanic Membrane Perforation 07/2000
1	Adenocarcinoma of Lung 04/2000
1	Mucoepidermoid Carcinoma 03/2000
1	Adenocarcinoma 03/2000
1	Lung Injury 02/2000
1	Large Cell Carcinoma 01/2000

Drug/Important Bio-Agent (IBA)

3	Proteins (Proteins, Gene)FDA Link 05/2001 - 06/2000
2	lipoarabinomannan (LAM)IBA 07/2009 - 11/2000
2	EnzymesIBA 08/2004 - 07/2001
2	Monoclonal AntibodiesIBA 07/2001 - 05/2001
2	Carcinoembryonic AntigenIBA 05/2001 - 03/2000
2	Pharmaceutical PreparationsIBA 01/2000 - 01/2000
1	Clarithromycin (Biaxin)FDA LinkGeneric 03/2014
1	Toll-Like Receptors (Toll-Like Receptor)IBA 09/2011
1	Formaldehyde (Formol)FDA Link 09/2011
1	Messenger RNA (mRNA)IBA 11/2006
1	MyostatinIBA 11/2006
1	myogenic factor 6IBA 11/2006
1	DNA (Deoxyribonucleic Acid)IBA 11/2006
1	Myogenic Regulatory FactorsIBA 11/2006
1	MyogeninIBA 11/2006
1	Amylases FDA Link 08/2004
1	Isradipine (Dynacirc)FDA LinkGeneric 06/2004
1	Nifedipine (Adalat)FDA LinkGeneric 06/2004
1	1,4-dihydropyridine (dihydropyridine)IBA 06/2004
1	Carbapenems (Carbapenem Antibiotics)IBA 12/2001
1	Meropenem (Merrem)FDA LinkGeneric 12/2001
1	Thymidine KinaseIBA 07/2001
1	ImmunosorbentsIBA 07/2001
1	Single-Chain AntibodiesIBA 05/2001
1	Interleukin-2 (IL2)IBA 05/2001
1	Recombinant DNA (Recombinant DNA Research)IBA 05/2001
1	CytokinesIBA 05/2001
1	phosphatidylcholine hydroperoxideIBA 04/2001
1	AntioxidantsIBA 04/2001
1	Acetylcysteine (Siran)FDA LinkGeneric 04/2001
1	Allopurinol (Remid)FDA LinkGeneric 04/2001
1	Biomarkers (Surrogate Marker)IBA 03/2001
1	hnRNP A2IBA 03/2001
1	Heterogeneous-Nuclear Ribonucleoproteins (Informatin)IBA 03/2001
1	Tumor Biomarkers (Tumor Markers)IBA 03/2001
1	DiureticsIBA 01/2001
1	CalciumIBA 01/2001
1	Endothelin Receptor AntagonistsIBA 01/2001
1	PicibanilIBA 11/2000
1	CollagenIBA 07/2000
1	Fibrin Tissue Adhesive (Fibrin Sealant)IBA 07/2000
1	Mucin-1 (CA 15-3 Antigen)IBA 04/2000
1	squamous cell carcinoma-related antigenIBA 04/2000
1	AntigensIBA 03/2000
1	Cadherins (E-Cadherin)IBA 03/2000
1	CarbohydratesIBA 03/2000
1	Biological ProductsIBA 03/2000
1	Keratins (Keratin)IBA 03/2000
1	alpha Catenin (alpha E-Catenin)IBA 03/2000
1	Superoxides (Superoxide)IBA 02/2000
1	Organ Preservation SolutionsIBA 01/2000

Therapy/Procedure

4	Therapeutics 06/2004 - 01/2000
4	Segmental Mastectomy (Lumpectomy) 07/2001 - 04/2000
4	Drug Therapy (Chemotherapy) 01/2001 - 01/2000
3	Combined Modality Therapy 01/2000 - 01/2000
2	X-Ray Film 08/2004 - 07/2001
2	Pneumonectomy (Lung Volume Reduction) 07/2001 - 01/2001
2	Thoracotomy 07/2001 - 02/2001
2	Sternotomy 01/2001 - 11/2000
2	Photochemotherapy (Photodynamic Therapy) 12/2000 - 05/2000
1	Artificial Respiration (Mechanical Ventilation) 01/2001
1	Chemoradiotherapy 12/2000
1	Transplantation 11/2000